Phage therapy is a medical form of biological control of bacterial infections, one that uses
naturally occurring viruses, called bacteriophages or phages, as antibacterial agents …

Staphylococcus aureus is a major cause of nosocomial and community‐acquired infections
and contributes to significant increase in morbidity and mortality especially when associated …

Enterococcus faecium has been classified as a “high priority” pathogen by the World Health
Organization. Enterococcus faecium has rapidly evolved as a global nosocomial pathogen …

Enterococcus faecium is a difficult-to-treat pathogen with emerging resistance to most
clinically available antibiotics. Daptomycin (DAP) is the standard of care, but even high DAP …

In recent years, bacteriophages (or phages) have reentered the spotlight as alternative or
adjuvant therapeutic agents to antibiotics. Their efficacy in more recalcitrant forms of …

Methicillin-resistant Staphylococcus aureus (MRSA) causes biofilm-related medical device
infections. Phage-antibiotic combinations offer potential therapy due to proven in vitro …

Enterococcus is a diverse genus of Gram-positive bacteria belonging to the lactic acid
bacteria (LAB) group. It is found in many environments, including the human gut and …

Multidrug-resistant (MDR) bacteria have become a growing threat to public health. The gram-
positive Enterococcus faecium is classified by WHO as a high-priority pathogen among the …

Phage therapy has (re) emerged as a serious possibility for combating multidrug-resistant
bacterial infections, including those caused by vancomycin-resistant Enterococcus faecium …

Enterococcus faecium is a member of the human gastrointestinal (GI) microbiota but can
also cause invasive infections, especially in immunocompromised hosts. Enterococci …